Light Chain Bioscience AG
Geneva, Switzerland · lightchainbio.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Light Chain Bioscience AG is a clinical-stage biotechnology company in Plan-Les-Ouates, Switzerland. It develops therapies based on its proprietary κλ body bispecific antibody platform for cancer and other serious indications.
They take quote requests by email.
What they offer
Bispecific antibody discovery and development
Advances native bispecific therapeutics using its proprietary κλ body platform.
CD47 targeting
Develops safe and selective CD47-targeting therapies on tumors.
CD28 targeting
Develops tumor-selective CD28 agonism approaches.
What they work on
- Modalities
- Antibody, Bispecific
- Assays and studies
- high throughput bsAb screening
- Instruments and platforms
- standard affinity chromatography
- Therapeutic areas
- cancer, other serious indications
- Sites
- Plan-Les-Ouates, Switzerland
Similar labs. AbTherx, Baopharma 宝济药业, DotBio, Invenra
Found in a contract services directory. Listing built from lightchainbio.com. Work here? Claim this listing.